144 related articles for article (PubMed ID: 31901907)
1. Carbonic anhydrase IX immunohistochemistry has potential to predict renal cell carcinoma outcomes: A systematic review and meta-analyses.
Samberkar S; Rajandram R; Mun KS; Samberkar P; Danaee M; Zulkafli IS
Malays J Pathol; 2019 Dec; 41(3):233-242. PubMed ID: 31901907
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of carbonic anhydrase IX immunohistochemical expression in renal cell carcinoma: a meta-analysis of the literature.
Zhao Z; Liao G; Li Y; Zhou S; Zou H; Fernando S
PLoS One; 2014; 9(11):e114096. PubMed ID: 25426861
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma.
Büscheck F; Fraune C; Simon R; Kluth M; Hube-Magg C; Möller-Koop C; Shadanpour N; Bannenberg C; Eichelberg C; Höflmayer D; Clauditz T; Wittmer C; Wilczak W; Sauter G; Fisch M; Rink M; Eichenauer T
Urol Oncol; 2018 Dec; 36(12):531.e19-531.e25. PubMed ID: 30322727
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
Stillebroer AB; Mulders PF; Boerman OC; Oyen WJ; Oosterwijk E
Eur Urol; 2010 Jul; 58(1):75-83. PubMed ID: 20359812
[TBL] [Abstract][Full Text] [Related]
6. A systematic review verified by bioinformatic analysis based on TCGA reveals week prognosis power of CAIX in renal cancer.
Zhang Z; Wu B; Shao Y; Chen Y; Wang D
PLoS One; 2022; 17(12):e0278556. PubMed ID: 36542612
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of carbonic anhydrase IX and KI67 as predictors of survival for renal clear cell carcinoma.
Bui MH; Visapaa H; Seligson D; Kim H; Han KR; Huang Y; Horvath S; Stanbridge EJ; Palotie A; Figlin RA; Belldegrun AS
J Urol; 2004 Jun; 171(6 Pt 1):2461-6. PubMed ID: 15126876
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of cytochrome P4A11 (CYP4A11), carbonic anhydrase 9 (CAIX) and Ki67 in renal cell carcinoma; diagnostic relevance and relations to clinicopathological parameters.
Elfakharany HK; Ghoraba HM; Gaweesh KA; Eldeen AAS; Eid AM
Pathol Res Pract; 2024 Jan; 253():155070. PubMed ID: 38183818
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma.
Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED
J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase IX (CAIX) is not an independent predictor of outcome in patients with clear cell renal cell carcinoma (ccRCC) after long-term follow-up.
Zhang BY; Thompson RH; Lohse CM; Dronca RS; Cheville JC; Kwon ED; Leibovich BC
BJU Int; 2013 Jun; 111(7):1046-53. PubMed ID: 23551810
[TBL] [Abstract][Full Text] [Related]
11. Quantification of carbonic anhydrase IX expression in serum and tissue of renal cell carcinoma patients using enzyme-linked immunosorbent assay: prognostic and diagnostic potentials.
Zhou GX; Ireland J; Rayman P; Finke J; Zhou M
Urology; 2010 Feb; 75(2):257-61. PubMed ID: 19963243
[TBL] [Abstract][Full Text] [Related]
12. [Value of MN/CAIX in the diagnosis of renal cell carcinoma].
Jiang YD; Ren F; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):412-4. PubMed ID: 22445996
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Kamei S; Deguchi T; Hirose Y
Oncol Rep; 2008 Sep; 20(3):525-30. PubMed ID: 18695901
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in patients with advanced renal cell carcinoma.
Muriel López C; Esteban E; Berros JP; Pardo P; Astudillo A; Izquierdo M; Crespo G; Sanmamed M; Fonseca PJ; Martínez-Camblor P
Clin Genitourin Cancer; 2012 Dec; 10(4):262-70. PubMed ID: 22959659
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and Clinicopathological Significance of Survivin Expression in Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Xie Y; Ma X; Gu L; Li H; Chen L; Li X; Gao Y; Fan Y; Zhang Y; Yao Y; Zhang X
Sci Rep; 2016 Jul; 6():29794. PubMed ID: 27411378
[TBL] [Abstract][Full Text] [Related]
16. Investigation of hypoxia and carbonic anhydrase IX expression in a renal cell carcinoma xenograft model with oxygen tension measurements and ¹²⁴I-cG250 PET/CT.
Lawrentschuk N; Lee FT; Jones G; Rigopoulos A; Mountain A; O'Keefe G; Papenfuss AT; Bolton DM; Davis ID; Scott AM
Urol Oncol; 2011; 29(4):411-20. PubMed ID: 19523858
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial.
Chamie K; Klöpfer P; Bevan P; Störkel S; Said J; Fall B; Belldegrun AS; Pantuck AJ
Urol Oncol; 2015 May; 33(5):204.e25-33. PubMed ID: 25823535
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers predicting outcome in patients with advanced renal cell carcinoma: Results from sorafenib phase III Treatment Approaches in Renal Cancer Global Evaluation Trial.
Peña C; Lathia C; Shan M; Escudier B; Bukowski RM
Clin Cancer Res; 2010 Oct; 16(19):4853-63. PubMed ID: 20651059
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of Membranous Carbonic Anhydrase IX Expression in Patients with Nonmetastatic Clear Cell Renal Cell Carcinoma of Different Tumor Stages.
Wang Y; Yin L; Cui Y; Wang L; Wu J; Wang J; Zhao H; Liu C; Cui Y; Zhang Y; Li X; Zhu Z; Yang L
Cancer Biother Radiopharm; 2022 Aug; 37(6):494-502. PubMed ID: 34714117
[No Abstract] [Full Text] [Related]
20. Prognostic impact of carbonic anhydrase IX expression in human renal cell carcinoma.
Sandlund J; Oosterwijk E; Grankvist K; Oosterwijk-Wakka J; Ljungberg B; Rasmuson T
BJU Int; 2007 Sep; 100(3):556-60. PubMed ID: 17608827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
